Prot #GO40800: A Phase Ib/II Study Evaluating the Safety and Efficacy of Idasanutlin in Combination with Cytarabine and Daunorubicin in Patients Newly Diagnosed with Acute Myeloid Leukemia (AML) and the Safety and Efficacy of Idasanutlin in the Maintenanc

Project: Research project

Project Details

StatusFinished
Effective start/end date9/24/19 → 9/24/22

Funding

  • Covance Inc. (Prot #GO40800 // Prot #GO40800)
  • Genentech, Inc (Prot #GO40800 // Prot #GO40800)